Trainee

Associate Professor of Pediatrics and Molecular Genetics, University of Toronto and The Hospital for Sick Children Dr. Mendoza has a long-standing interest in the genetics of skeletal dysplasias, inherited bone disorders and connective tissue disorders, and also serves as Interim Division Head of Clinical and Metabolic Genetics at the University. ASHG: What academic or extracurricular... Read More

Kathryn (Kate) Garber, PhD, is an Associate Professor at Emory University and Chair of the ASHG Communications Committee. She has been a member of ASHG since 2007. ASHG: Tell us about your position and how it fits into your institution and its goals. Dr. Garber: I have three main pieces to my job: teaching, working in a clinical... Read More

Posted by: Douglas F. Dluzen, PhD, ASHG Training & Development Committee It’s fitting that the March for Science shared the spotlight with Earth Day. During the slow march down Constitution Avenue, I saw several signs sticking out from the crowd reminding the world that there is no Planet B, no other options. It was also... Read More

Trainee Author: Douglas Dluzen, PhD Postdoctoral Fellow National Institute on Aging (Photo courtesy Dr. Dluzen) Dluzen DF et al. Racial differences in microRNA and gene expression in hypertensive women. Sci Rep. 2016 Oct 25;6:35815. doi: 10.1038/srep35815. This paper emphasizes the importance of miRNA on population specific gene expression patterns. Dluzen et al. demonstrate that differential expression of a set... Read More

Contributed by TDC member Julie Jurgens May 2017 ASHG: What are some of the genetic policy items that ASHG is currently discussing? Dr. Scholes: The Preserving Employee Wellness Programs Act (HR1313) is currently a major focus. This legislation, recently introduced in the U.S. Congress, would eviscerate key genetic privacy protections in the Genetic Information Nondiscrimination Act (GINA). GINA prevents employers... Read More